GO:0006564 L-serine biosynthetic process: Metabolic Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006564 (L-serine biosynthetic process) describes the chemical reactions and pathways that produce L-serine, a non-essential amino acid with essential roles in metabolism and neurotransmission [4,6].
• In humans, L-serine is synthesized primarily via the phosphorylated pathway, which converts the glycolytic intermediate 3-phosphoglycerate to L-serine through three enzymatic steps.
• Key enzymes include PHGDH, PSAT1, and PSPH; their expression and activity are tightly regulated to meet cellular demands for serine.
• Impaired L-serine biosynthesis is linked to neurological disorders such as Alzheimer's disease and to metabolic dysfunction in conditions like insulin resistance [1,2].
• L-serine biosynthesis supports glutathione production and antioxidant defense, as shown in yeast metabolic engineering studies.
• Research on this pathway employs CRISPR knockout, point mutation, knock-in, and overexpression models, combined with metabolomics, transcriptomics, and flux analysis [3,8].
Description
L-serine is a non-essential amino acid that serves as a precursor for proteins, nucleotides, lipids, and neurotransmitters [4,6]. The L-serine biosynthetic process (GO:0006564) encompasses the biochemical reactions that generate L-serine from metabolic intermediates, primarily through the phosphorylated pathway in humans. This pathway is critical for cellular metabolism, as it links glycolysis to amino acid biosynthesis and supports one-carbon metabolism. Dysregulation of L-serine biosynthesis has been implicated in a range of pathologies, including neurodegenerative diseases, metabolic disorders, and cancer [1,2,3]. For researchers, understanding the molecular players and regulatory mechanisms of this pathway is essential for developing targeted therapies and for interpreting metabolic phenotypes in disease models [4,7]. This article provides a comprehensive overview of the L-serine biosynthetic process, its genetic components, and the experimental strategies used to study it.
L-serine biosynthetic process At A Glance
| GO ID | GO:0006564 |
|---|---|
| GO term | L-serine biosynthetic process |
| Ontology | biological_process |
| Synonym | L-serine anabolism, L-serine biosynthesis, L-serine formation, L-serine synthesis |
| Major function | Production of L-serine from metabolic precursors |
| Key enzymes | PHGDH, PSAT1, PSPH |
| Pathway | Phosphorylated pathway (primary in humans) |
| Subcellular location | Cytosol (enzymes of the phosphorylated pathway) |
What Is GO:0006564?
The L-serine biosynthetic process (GO:0006564) is defined as the chemical reactions and pathways resulting in the formation of L-serine. This biological process includes the enzymatic conversion of precursors such as 3-phosphoglycerate into L-serine, typically through a series of phosphorylation and transamination steps. The term is synonymous with L-serine anabolism, biosynthesis, formation, and synthesis.
Why Is L-serine biosynthetic process Important in Cell Biology?
The L-serine biosynthetic process is fundamental to cellular metabolism because L-serine is a building block for proteins and a precursor for numerous biomolecules, including nucleotides, sphingolipids, and the antioxidant glutathione [5,6]. In the nervous system, L-serine produced by astrocytes supports neuronal function and neurotransmission. Perturbations in this pathway have been linked to Alzheimer's disease, where impaired glycolysis-derived serine production in astrocytes contributes to cognitive deficits. Moreover, L-serine biosynthesis influences insulin sensitivity and fatty acid oxidation, as activation of SIRT1 by L-serine reverses insulin resistance in muscle cells. In cancer, L-serine uptake and metabolism are reprogrammed to support rapid proliferation, and targeting this pathway is a potential therapeutic strategy. Thus, understanding the regulation and genetic control of L-serine biosynthesis is crucial for both basic biology and translational research.
• Provides L-serine for protein synthesis and one-carbon metabolism.
• Supports neurotransmitter synthesis and neuronal health.
• Contributes to antioxidant defense via glutathione production.
• Linked to Alzheimer's disease through astrocytic serine deficiency.
• Modulates insulin resistance and fatty acid oxidation in muscle.
• Reprogrammed in cancers to sustain proliferation.
• Involved in podocyte injury and senescence in kidney disease.
• Target for metabolic engineering in yeast for glutathione overproduction.
• Essential for embryonic development and neurological function.
• Offers opportunities for CRISPR-based disease modeling and drug discovery [3,8].
What Happens During L-serine biosynthetic process?
Step 1: Conversion of 3-phosphoglycerate to 3-phosphohydroxypyruvate
In simple terms: The pathway starts by modifying a glycolysis intermediate.
The first committed step of the phosphorylated pathway is the oxidation of 3-phosphoglycerate (3-PG) to 3-phosphohydroxypyruvate (3-PHP), catalyzed by the enzyme PHGDH (phosphoglycerate dehydrogenase). This reaction requires NAD+ as a cofactor and is rate-limiting for the pathway. PHGDH is allosterically inhibited by L-serine, providing feedback regulation.
Step 2: Transamination to phosphoserine
In simple terms: A nitrogen group is added to the intermediate.
In the second step, 3-phosphohydroxypyruvate is transaminated to phosphoserine (PSer) by PSAT1 (phosphoserine aminotransferase), using glutamate as the amino donor. This reaction converts the keto acid to an amino acid, incorporating nitrogen into the serine backbone. PSAT1 is a pyridoxal phosphate-dependent enzyme.
Step 3: Dephosphorylation to L-serine
In simple terms: The final step removes a phosphate group to yield serine.
Phosphoserine phosphatase (PSPH) catalyzes the hydrolysis of phosphoserine to L-serine, releasing inorganic phosphate. This step is irreversible and completes the phosphorylated pathway. PSPH is also subject to feedback inhibition by L-serine.
Alternative pathways and compartmentalization
In simple terms: Serine can also be made by other routes, but the phosphorylated pathway is main in humans.
In addition to the phosphorylated pathway, L-serine can be synthesized from glycine via serine hydroxymethyltransferase (SHMT) in the reverse direction, but this is not a net biosynthetic route in humans. The phosphorylated pathway enzymes are cytosolic, and their expression varies across tissues, with high levels in the brain, liver, and kidney. In astrocytes, glycolysis-derived serine production is critical for neuronal support.
Key Genes Involved in GO:0006564 L-serine biosynthetic process
The following genes encode enzymes and transporters directly involved in L-serine biosynthesis and related metabolic processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PHGDH | Catalyzes first step of phosphorylated pathway | Rate-limiting enzyme; target in cancer and neurodegeneration [3,7] |
| PSAT1 | Transaminates 3-phosphohydroxypyruvate to phosphoserine | Defects cause serine deficiency disorders |
| PSPH | Dephosphorylates phosphoserine to L-serine | Final step; feedback regulated |
| SHMT1 | Interconverts serine and glycine | Links serine metabolism to one-carbon cycle |
| SHMT2 | Mitochondrial serine hydroxymethyltransferase | Supports mitochondrial one-carbon metabolism |
| SLC1A4 | L-serine transporter | Mediates serine uptake; target in cancer |
| SLC7A5 | Amino acid transporter | Involved in serine uptake in some cells |
| SIRT1 | Deacetylase activated by L-serine | Mediates serine effects on insulin resistance |
| GCLC | Glutamate-cysteine ligase catalytic subunit | Glutathione synthesis; influenced by serine availability |
| GCLM | Glutamate-cysteine ligase modifier subunit | Glutathione synthesis; influenced by serine availability |
| MTHFD1 | One-carbon metabolism enzyme | Links serine to nucleotide synthesis |
| MTHFD2 | Mitochondrial one-carbon enzyme | Supports serine-derived one-carbon units |
| PDK1 | Pyruvate dehydrogenase kinase | Regulates glycolytic flux to serine |
| PKM | Pyruvate kinase | Affects glycolytic intermediates for serine synthesis |
| GAPDH | Glycolytic enzyme | Provides 3-PG for serine synthesis |
| PGAM1 | Phosphoglycerate mutase | Modulates 3-PG levels for serine synthesis |
How Is L-serine biosynthetic process Regulated?
L-serine biosynthesis is regulated at multiple levels. The phosphorylated pathway enzymes are subject to feedback inhibition by L-serine: PHGDH is allosterically inhibited by L-serine, and PSPH is also inhibited by its product. Transcriptional regulation occurs via the transcription factor ATF4, which is activated by the integrated stress response (ISR) and upregulates PHGDH, PSAT1, and PSPH under amino acid deprivation. In cancer, oncogenic signaling such as mTORC1 promotes serine synthesis to support proliferation. Additionally, the availability of glycolytic intermediates, particularly 3-phosphoglycerate, links serine biosynthesis to glucose metabolism. In astrocytes, impaired glycolysis reduces serine production, contributing to Alzheimer's disease pathology.
L-serine biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PHGDH | Cancer, neurodegeneration | Knockout and overexpression in cancer cell lines [3,7] |
| PSAT1 | Serine deficiency disorders | Point mutation knock-in in patient-derived cells |
| PSPH | Neurological deficits | Knockout in neuronal cultures |
| SLC1A4 | Gastric cancer | Knockout in gastric cancer cells |
| SIRT1 | Insulin resistance | Overexpression in C2C12 myotubes |
Alzheimer's disease
Impaired glycolysis-derived L-serine production in astrocytes contributes to cognitive deficits in Alzheimer's disease. Reduced serine synthesis leads to decreased neuronal support and neurotransmitter imbalance. This highlights the importance of astrocytic serine biosynthesis in brain health.
Cancer
Many cancers upregulate serine biosynthesis to meet the demands of rapid proliferation. PHGDH is amplified or overexpressed in certain tumors, and targeting serine synthesis or uptake (e.g., via SLC1A4) is a potential therapeutic strategy. Inhibition of SLC1A4-mediated serine uptake promotes mitochondrial damage in gastric cancer cells.
Metabolic disorders
L-serine activates SIRT1, leading to increased fatty acid oxidation and reversal of insulin resistance in muscle cells. This links serine biosynthesis to metabolic health and suggests that modulating this pathway could improve insulin sensitivity.
Kidney disease
Impaired glycolysis-derived serine metabolism drives podocyte injury and senescence, contributing to kidney disease progression. Maintaining serine synthesis may protect podocytes from damage.
From L-serine biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PHGDH loss affect cancer cell proliferation? | PHGDH knockout in cancer cell lines |
| Does a specific PSAT1 mutation cause serine deficiency? | Point mutation knock-in in iPSCs |
| Can overexpression of PSPH rescue serine auxotrophy? | PSPH overexpression in knockout cells |
| How does SLC1A4 inhibition affect serine uptake? | SLC1A4 knockout or inhibitor treatment |
| Does L-serine supplementation reverse insulin resistance? | SIRT1 overexpression in C2C12 myotubes |
| What is the role of astrocytic serine synthesis in cognition? | Astrocyte-specific PHGDH knockout in mice |
How to Study the L-serine biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Levels of serine and pathway intermediates | Quantify pathway activity |
| 13C flux analysis | Flux through serine synthesis | Determine contribution of glycolysis |
| RNA-seq | Gene expression changes | Identify regulatory networks |
| Western blot | Protein levels of PHGDH, PSAT1, PSPH | Validate expression changes |
| Enzyme activity assay | Catalytic activity of pathway enzymes | Characterize mutants |
| CRISPR knockout screen | Genes essential for serine synthesis | Identify new targets |
| Immunofluorescence | Subcellular localization of enzymes | Study compartmentalization |
Metabolomics and flux analysis
Metabolomics using mass spectrometry can quantify L-serine and intermediates of the phosphorylated pathway. Stable isotope tracing with 13C-glucose or 13C-serine allows measurement of flux through the pathway [2,7]. These methods are essential for assessing pathway activity in cells and tissues.
Transcriptomics and proteomics
RNA-seq and proteomics can reveal changes in expression of PHGDH, PSAT1, PSPH, and related genes under different conditions. This helps identify regulatory mechanisms and potential therapeutic targets.
Enzyme activity assays
In vitro enzyme assays using recombinant PHGDH, PSAT1, or PSPH can measure catalytic activity and kinetics. These assays are used to study mutations and inhibitors.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes that are essential for L-serine biosynthesis or that mediate sensitivity to serine deprivation. Such screens have uncovered SLC1A4 as a key transporter in gastric cancer.
How CRISPR Can Be Used to Study GO:0006564 L-serine biosynthetic process
Knockout
CRISPR knockout of PHGDH, PSAT1, or PSPH can create serine auxotrophic cell lines, which are useful for studying the requirement for L-serine biosynthesis in proliferation and survival [3,7]. Knockout of SLC1A4 reduces serine uptake and induces mitochondrial damage in gastric cancer cells.
Point Mutation
Introducing specific point mutations in PHGDH or PSAT1 via CRISPR can model human serine deficiency disorders and reveal structure-function relationships. For example, mutations that affect allosteric regulation by L-serine can be studied.
Knock-in
Knock-in of tagged versions of PHGDH or PSPH allows for affinity purification and interaction studies. Knock-in of disease-associated mutations in PSAT1 can recapitulate patient phenotypes in cell models.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase expression of PHGDH, PSAT1, or PSPH to study the effects of pathway activation on metabolism and disease. Overexpression of SIRT1 in C2C12 myotubes was used to study L-serine effects on insulin resistance.
How EDITGENE Supports L-serine biosynthetic process Research
Researchers studying L-serine biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to create precise cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for L-serine biosynthetic process research.
Frequently Asked Questions About L-serine biosynthetic process
What is L-serine biosynthetic process?
It is the set of biochemical reactions that produce L-serine, primarily via the phosphorylated pathway in humans.
What genes are involved in L-serine biosynthetic process?
Key genes include PHGDH, PSAT1, and PSPH, which encode the enzymes of the phosphorylated pathway.
What is the GO ID for L-serine biosynthetic process?
The GO ID is GO:0006564.
How is L-serine biosynthesis regulated?
It is regulated by feedback inhibition by L-serine, transcriptional activation via ATF4, and availability of glycolytic intermediates.
Why is L-serine biosynthesis important in the brain?
Astrocytes produce L-serine to support neuronal function, and impaired synthesis contributes to cognitive deficits in Alzheimer's disease [2,4].
Can L-serine biosynthesis be targeted in cancer?
Yes, many cancers upregulate serine synthesis, and inhibiting PHGDH or serine transporters like SLC1A4 is a potential therapeutic strategy.
What diseases are associated with defects in L-serine biosynthesis?
Defects are linked to neurological disorders, metabolic syndrome, and kidney disease [1,2,6,8].
How can CRISPR be used to study L-serine biosynthesis?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional studies of pathway genes [3,7].
What methods measure L-serine biosynthesis activity?
Metabolomics, isotope tracing, enzyme assays, and transcriptomics are commonly used [2,7].
What is the role of SIRT1 in L-serine metabolism?
L-serine activates SIRT1, which increases fatty acid oxidation and reverses insulin resistance in muscle cells.
Conclusion
The L-serine biosynthetic process (GO:0006564) is a central metabolic pathway with far-reaching implications for cellular function and human disease. From supporting neurotransmission and antioxidant defense to driving cancer proliferation, the enzymes and regulators of this pathway are promising targets for therapeutic intervention. Continued research using advanced CRISPR models and multi-omics approaches will further elucidate its roles and unlock new treatment strategies.
References
- 1. Sim WC et al.. 2019. Activation of SIRT1 by L-serine increases fatty acid oxidation and reverses insulin resistance in C2C12 myotubes.. Cell Biol Toxicol 35(5):457-470 PMID: 30721374
- 2. Le Douce J et al.. 2020. Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer's Disease.. Cell Metab 31(3):503-517.e8 PMID: 32130882
- 3. Zhao J et al.. 2025. Skullcapflavone II Inhibits SLC1A4-Mediated L-Serine Uptake and Promotes Mitochondrial Damage in Gastric Cancer.. Adv Sci (Weinh) 12(45):e17225 PMID: 40971730
- 4. Maugard M et al.. 2021. l-Serine links metabolism with neurotransmission.. Prog Neurobiol 197:101896 PMID: 32798642
- 5. Kobayashi J et al.. 2022. Metabolic engineering of the L-serine biosynthetic pathway improves glutathione production in Saccharomyces cerevisiae.. Microb Cell Fact 21(1):153 PMID: 35933377
- 6. de Koning TJ et al.. 2003. L-serine in disease and development.. Biochem J 371(Pt 3):653-61 PMID: 12534373
- 7. Murtas G et al.. 2020. L-serine synthesis via the phosphorylated pathway in humans.. Cell Mol Life Sci 77(24):5131-5148 PMID: 32594192
- 8. Hu H et al.. 2025. Impaired glycolysis-derived serine metabolism as a key driver of podocyte injury with senescence.. Nat Commun 17(1):138 PMID: 41345115
